Latest news
-
Scientists reveal how signals from pathogenic bacteria reach danger sensors of cells
09/29/2016
Researchers identify the molecular events that activate inflammasomes to initiate the innate immune response against bacterial invaders.
-
Newly discovered immune cell type protects against lung infections during chemotherapy
09/26/2016
Newly recognized lung macrophage protects chemotherapy-treated mice with a depleted immune system from lethal bacterial pneumonia
-
New mobile health app will help sickle cell patients stay healthy
09/21/2016
National Institutes of Health funding will help physicians and researchers improve hydroxyurea treatment management for sickle cell patients in Memphis.
-
St. Jude and Methodist Healthcare sign agreement to advance center for adult sickle cell disease in Memphis
09/19/2016
The newly expanded Methodist Comprehensive Sickle Cell Center will strengthen research into sickle cell disease and serve the growing needs of patients in the Memphis area.
-
St. Jude Children’s Research Hospital and Sanger Institute, UK collaborate to make data beautiful
09/16/2016
Proteinpaint database collaboration will make it easier for any scientist to explore cancer genome data.
Media contacts
Our media relations staff will help you set up interviews, media visits or answer your questions about the hospital.
Media Tools
Facts for Media
Quick information for journalists about St. Jude Children’s Research Hospital, located in Memphis, Tennessee.
About St. Jude
St. Jude is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases.
Public service announcements
Encourage your readers, listeners or viewers to support our lifesaving mission by sharing our PSAs.
-
Scientists reveal how signals from pathogenic bacteria reach danger sensors of cells
Researchers identify the molecular events that activate inflammasomes to initiate the innate immune response against bacterial invaders.
-
For kids, by kids
At only 6 years old, St. Jude supporter Eleanor has raised funds and recruited others in her passion to help children at St. Jude.
-
Meet Maddalynn and Maziya
Sharing the same diagnosis of sickle cell disease as her little sister, Maddalynn, Maziya and her family were better able to help Maddalynn with her treatment.
-
Saving lives of children around the world
Did you know that the efforts of St. Jude save the lives of young patients not just in the United States, but worldwide? Get the facts.
-
Support St. Jude on Giving Tuesday
Support St. Jude on #GivingTuesday. At St. Jude, no family pays St. Jude for anything — because all a family should worry about is helping their child live.
-
Fighting life-threatening diseases
St. Jude is at the forefront of fighting many diseases that threaten children’s lives, including sickle cell, influenza and malaria.
-
Four ways sharing is caring at St. Jude
At St. Jude, we work just as hard to share our discoveries with the scientific community as we do in making them.
-
How your donation makes an impact
Every dollar makes a difference. Get the facts about how your donation could be used, and how it helps to save the lives of children everywhere.
-
Why St. Jude stands out
Already be familiar with the lifesaving work going on at St. Jude? Here's a few things that could surprise you.
-
St. Jude Blogger Ambassador Program
Make a difference with each post. Meet the bloggers who are generating awareness and support for the kids of St. Jude, and sign up to become one yourself.
-
Targeted antibiotics may help protect bacterial good guys in the gut
Targeted antibiotic is easier on the gut microbiome; highlights a possible antibiotic drug development strategy
-
Finding new ways to protect patients during chemo
Newly identified type of lung macrophage protects chemotherapy-treated mice from lethal bacterial pneumonia despite absence of neutrophils.
-
St. Jude hosts Survivors’ Day
St. Jude welcomed long-term survivors and current patients for a fun-filled day of activities. View the images from the event.
-
Investigational immunotherapy drug shrinks tumors in high-risk neuroblastoma patients
Preliminary report: Neuroblastoma tumors shrank in more pediatric patients when experimental immunotherapy was combined with chemotherapy
-
Ewing Sarcoma: Changing Hues
A spectrum of discoveries in St. Jude labs and clinics offer promise for patients with Ewing sarcoma.
